Skip to content
Menu

Wells Fargo Upgrades Praxis Precision Medicine to Overweight, Raises Price Target to $509

Benzinga Newsdesk 14 hours ago

Analyst RatingsNewsUpgradesPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Wells Fargo analyst Benjamin Burnett upgrades Praxis Precision Medicine (NASDAQ:PRAX) from Equal-Weight to Overweight and raises the price target from $343 to $509.

Wells Fargo analyst Benjamin Burnett upgrades Praxis Precision Medicine (NASDAQ:PRAX) from Equal-Weight to Overweight and raises the price target from $343 to $509.

Read at benzinga.com